
The condemnation came as the House of Lords debated regulations paving the way for a scheme which would require animal lovers on the British mainland to have documentation in order to visit Northern Ireland. Critics view the move as further evidence of Northern Ireland still having to follow EU rules post-Brexit and being treated differently from the rest of the UK – a major source of contention to the unionist community. The paperwork, which will be free to apply for, includes a declaration that the owner will not travel onwards to Ireland or another EU country with their pet or assistance dog. Animals will have to be microchipped and have their own individual pet travel document, which will be valid for its lifetime. Northern Ireland residents returning after a stay in Great Britain with their pet or assistance dog will not need a travel document. The scheme is being introduced under the Windsor Framework, a revised deal for Northern Ireland’s post-Brexit trading arrangements aimed at tackling issues caused by the protocol. Raising her concerns in Parliament, Baroness Hoey, a Northern Irish Brexit supporter and former Labour MP, said: “These regulations are in effect about a new aspect of the Irish Sea border that has not had expression until this point because of the grace periods.” She added: “The experience of visiting Northern Ireland with your pet dog or cat, or even a ferret, will be made to feel like a visit to a foreign country. Lady Hoey went on: “This could spell the end of holiday trips for pet owners from GB to NI and then on to the Republic, when they want to explore both Northern Ireland and the Republic. “If they have a pet passport, they will have renounced their right to go to the Republic. That makes the border more of an obstruction than having border control posts on it, because at least in that eventuality, you could still cross over it.” Rejecting claims it was a result of the UK leaving the EU, she said: “The reality is that this is happening precisely because Northern Ireland has not got Brexit. “As we say repeatedly, it is still subject to EU rules and the EU could change the rules overnight.” Former DUP deputy leader Lord Dodds of Duncairn said: “Every one of the statutory instruments that come forward under the Windsor Framework must be properly debated, because these laws are being brought forward to implement what a foreign jurisdiction has decided should be the law of the United Kingdom. “In the 21st century, we should not accept colonial rule. We abolished it elsewhere. We believe it should not be tolerated for one second. People should have the democratic right to decide their laws for themselves, in their interests.” He added: “The ridiculous part about this debate is that we are having to debate European laws regulating the movement of pet animals owned by British citizens between one part of the United Kingdom and another. That is an outrage.” Lord Dodds went on: “As I said, there will be hundreds, thousands more of these regulations, in all areas, affecting the daily lives of people in Northern Ireland. They all add up to a grievous assault on Northern Ireland’s constitutional position.” But former leader of the Social Democratic and Labour Party (SDLP) Baroness Ritchie of Downpatrick said: “I support the Windsor Framework because it is a necessary legal device to deal with the complexities that were presented to us in Ireland, north and south, on the issue of Brexit. “We need a pragmatic solution rather than choosing to have political contests and duels simply for the sake of them.” Introducing the regulations, environment minister Baroness Hayman of Ulloch said: “This scheme will simplify the requirements associated with moving pet dogs, cats and ferrets from Great Britain to Northern Ireland significantly. “It replaces single-use animal health certificates with a free-of-charge lifelong travel document and removes the need for costly pet health treatments. “Pet owners who travel frequently with their pets, or those who rely on the services of an assistance dog to travel independently, will benefit substantially from this change in approach.” However, she acknowledged the concerns raised by peers and promised to continue engagement with them.The condemnation came as the House of Lords debated regulations paving the way for a scheme which would require animal lovers on the British mainland to have documentation in order to visit Northern Ireland. Critics view the move as further evidence of Northern Ireland still having to follow EU rules post-Brexit and being treated differently from the rest of the UK – a major source of contention to the unionist community. The paperwork, which will be free to apply for, includes a declaration that the owner will not travel onwards to Ireland or another EU country with their pet or assistance dog. Animals will have to be microchipped and have their own individual pet travel document, which will be valid for its lifetime. Northern Ireland residents returning after a stay in Great Britain with their pet or assistance dog will not need a travel document. The scheme is being introduced under the Windsor Framework, a revised deal for Northern Ireland’s post-Brexit trading arrangements aimed at tackling issues caused by the protocol. Raising her concerns in Parliament, Baroness Hoey, a Northern Irish Brexit supporter and former Labour MP, said: “These regulations are in effect about a new aspect of the Irish Sea border that has not had expression until this point because of the grace periods.” She added: “The experience of visiting Northern Ireland with your pet dog or cat, or even a ferret, will be made to feel like a visit to a foreign country. Lady Hoey went on: “This could spell the end of holiday trips for pet owners from GB to NI and then on to the Republic, when they want to explore both Northern Ireland and the Republic. “If they have a pet passport, they will have renounced their right to go to the Republic. That makes the border more of an obstruction than having border control posts on it, because at least in that eventuality, you could still cross over it.” Rejecting claims it was a result of the UK leaving the EU, she said: “The reality is that this is happening precisely because Northern Ireland has not got Brexit. “As we say repeatedly, it is still subject to EU rules and the EU could change the rules overnight.” Former DUP deputy leader Lord Dodds of Duncairn said: “Every one of the statutory instruments that come forward under the Windsor Framework must be properly debated, because these laws are being brought forward to implement what a foreign jurisdiction has decided should be the law of the United Kingdom. “In the 21st century, we should not accept colonial rule. We abolished it elsewhere. We believe it should not be tolerated for one second. People should have the democratic right to decide their laws for themselves, in their interests.” He added: “The ridiculous part about this debate is that we are having to debate European laws regulating the movement of pet animals owned by British citizens between one part of the United Kingdom and another. That is an outrage.” Lord Dodds went on: “As I said, there will be hundreds, thousands more of these regulations, in all areas, affecting the daily lives of people in Northern Ireland. They all add up to a grievous assault on Northern Ireland’s constitutional position.” But former leader of the Social Democratic and Labour Party (SDLP) Baroness Ritchie of Downpatrick said: “I support the Windsor Framework because it is a necessary legal device to deal with the complexities that were presented to us in Ireland, north and south, on the issue of Brexit. “We need a pragmatic solution rather than choosing to have political contests and duels simply for the sake of them.” Introducing the regulations, environment minister Baroness Hayman of Ulloch said: “This scheme will simplify the requirements associated with moving pet dogs, cats and ferrets from Great Britain to Northern Ireland significantly. “It replaces single-use animal health certificates with a free-of-charge lifelong travel document and removes the need for costly pet health treatments. “Pet owners who travel frequently with their pets, or those who rely on the services of an assistance dog to travel independently, will benefit substantially from this change in approach.” However, she acknowledged the concerns raised by peers and promised to continue engagement with them.
GAINESVILLE, Fla. (AP) — DJ Lagway threw two touchdown passes, Montrell Johnson ran for 127 yards and a score, and Florida upset No. 9 Mississippi 24-17 on Saturday to knock the Rebels out of College Football Playoff contention. The Gators (6-5, 4-4 Southeastern Conference), who topped LSU last week, beat ranked teams in consecutive weeks for the first time since 2008 and became bowl eligible. The late-season spurt provided another vote of confidence for coach Billy Napier, who is expected back for a fourth season. Ole Miss (8-3, 4-3), which entered the day as a 10-point favorite, lost for the first time in four games and surely will drop out of the 12-team playoff picture. The Rebels ranked ninth in the latest CFP and needed only to avoid stumbling down the stretch against Florida and lowly Mississippi State to clinch a spot in the playoff field. But coach Lane Kiffin’s team failed to score in three trips inside the red zone and dropped countless passes in perfect weather. No. 2 OHIO ST. 38, No. 5 INDIANA 15 COLUMBUS, Ohio (AP) — Will Howard passed for two touchdowns and rushed for another, TreVeyon Henderson ran for a score and No. 2 Ohio State beat previously undefeated No. 5 Indiana. All Ohio State (10-1, 7-1 Big Ten, CFP No. 2) has to do now is beat Michigan at home next Saturday and it will earn a return to the Big Ten championship game for the first time since 2020 and get a rematch with No. 1 Oregon. The Ducks beat Ohio State 32-31 in a wild one back on Oct. 12. The Hoosiers (10-1, 7-1, No. 5 CFP) had their best chance to beat the Buckeyes for the first time since 1988 but were hurt by special teams mistakes and disrupted by an Ohio State defense that sacked quarterback Kurtis Rourke five times. Howard finished 22 for 26 for 201 yards. Emeka Egbuka had seven catches for 80 yards and a TD. No. 8 GEORGIA 59, UMass 21 ATHENS, Ga. (AP) — Carson Beck threw four touchdown passes, Nate Frazier ran for 136 yards with three scores and No. 8 Georgia overwhelmed Massachusetts as the Bulldogs tried to protect their College Football Playoff hopes. Georgia (9-2, No. 10 CFP) needed the big offense from Beck and Frazier to rescue a defense that gave up 226 rushing yards. UMass (2-9) played its first game under interim coach Shane Montgomery, the offensive coordinator who retained his play-calling duties after replacing fired coach Don Brown on Monday. Jalen John led the Minutemen with 107 rushing yards and a touchdown. Georgia extended its streak of consecutive home wins to 30, the longest active streak in the Football Bowl Subdivision. No. 10 TENNESSEE 56, UTEP 0 KNOXVILLE, Tenn. (AP) — Nico Iamaleava threw for 209 yards and four touchdowns to lead No. 10 Tennessee to a victory over UTEP. The Volunteers (9-2) overcame a sluggish start to roll up the impressive win. Both teams were scoreless in the first quarter, but Tennessee found its rhythm. Grad student receiver Bru McCoy, who hadn’t caught a touchdown pass this season, had two. Peyton Lewis also ran for two scores. Tennessee’s defensive line, which had no sacks in last week’s loss to Georgia, had three against the Miners. UTEP (2-9) struggled with two missed field goals and three turnovers. Tennessee’s offense came alive with 28 points in the second quarter. In the final four drives of the quarter, Iamaleava completed 11 of 12 passes for 146 yards and touchdowns to Squirrel White, Ethan Davis and McCoy. No. 11 MIAMI 42, WAKE FOREST 14 MIAMI GARDENS, Fla. (AP) — Cam Ward passed for 280 yards and threw two touchdowns to Jacolby George on another record-breaking day, Mishael Powell ran an interception back 76 yards for a touchdown and No. 11 Miami pulled away late to beat Wake Forest. The Hurricanes (10-1, 6-1 Atlantic Coast Conference, No. 8 College Football Playoff) can clinch a berth in the ACC title game with a win at Syracuse next weekend. Ward completed 27 of 38 passes, plus ran for a score. He broke two more single-season Miami records, both of which had been held for 40 years by Bernie Kosar — most passing yards in a season and most completions in a season. Ward now has 3,774 yards on 268 completions this season. Kosar threw for 3,642 yards on 262 completions in 1984. Demond Claiborne had a 100-yard kickoff return for a touchdown for Wake Forest (4-7, 2-5). Claiborne also rushed for 62 yards for the Demon Deacons, and starting quarterback Hank Bachmeier was 8 of 14 passing for 86 yards and a touchdown. No. 13 SMU 33, VIRGINIA 7 CHARLOTTESVILLE, Va. (AP) — Kevin Jennings threw for a career-high 323 yards and two touchdowns and ran for another, and No. 13 SMU clinched a spot in the Atlantic Coast Conference championship game by routing Virginia. Isaiah Smith and Jared Harrison-Hunte each had two sacks to help the Mustangs (10-1, 7-0, No. 13 CFP) extend their winning streak to eight. They would earn an automatic bid into the expanded College Football Playoff by beating 11th-ranked Miami or 17th-ranked Clemson in the ACC title game on Dec. 7 in Charlotte, North Carolina. SMU had to get there first, and Jennings led the way again, bouncing back from an interception and a fumble to complete 25 of 33 passes to six different receivers, including TD tosses to Jordan Hudson and Matthew Hibner. Brashard Smith provided a little balance on offense, running for 63 yards and his 13th touchdown of the season. SMU’s defense overwhelmed UVa’s offensive line, sacking Anthony Colandrea nine times and allowing the Cavaliers (5-6, 3-4) just 173 yards. Special teams contributed, too, with Roderick Daniels Jr. returning a punt 48 yards and Collin Rogers making two field goals. No. 24 ILLINOIS 38, RUTGERS 31 PISCATAWAY, N.J. (AP) — Luke Altmyer found Pat Bryant for a catch-and-run, 40-yard touchdown pass with 4 seconds left, sending No. 24 Illinois to a wild victory over Rutgers. Illinois (8-3, 5-3 Big Ten) was down 31-30 when it sent long kicker Ethan Moczulski out for a desperation 58-yard field goal with 14 seconds to go. Rutgers coach Greg Schiano then called for a timeout right before Moczulski’s attempt was wide left and about 15 yards short. After the missed field goal was waved off by the timeout, Illinois coach Bret Bielema sent his offense back on the field. Altmyer hit Bryant on an in cut on the left side at the 22, and he continued across the field and scored untouched in a game that featured three lead changes in the final 3:07. Rutgers (6-5, 3-5) gave up a safety on the final kickoff return, throwing a ball out of bounds in the end zone as players passed it around hoping for a miracle touchdown. Altmyer was 12-of-26 passing for 249 yards and two touchdowns. Bryant finished with seven receptions for 197 yards.Morrisons boss blasts ‘avalanche’ of Budget costs amid warnings of higher prices and fewer workers
SEOUL, South Korea , Nov. 27, 2024 /PRNewswire/ -- Hyundai Motor Company and Kia Corporation have unveiled a reliable companion for industrial work, the wearable robot 'X-ble Shoulder.' This device, just by being worn, can increase workers' efficiency and reduce musculoskeletal injuries. Two videos released on Hyundai Motor Group's YouTube channel show the X-ble Shoulder in action, including product features and the development story . Hyundai Motor and Kia unveiled the X-ble Shoulder at Wearable Robot Tech Day held at the Hyundai Motorstudio Goyang near Seoul . The X-ble brand — a combination of 'X,' symbolizing infinite potential, and 'able,' indicating that anything can be realized — heralds a new era in wearable technology. The X-ble Shoulder, the first product in the X-ble line, is an industrial wearable robot developed by Hyundai Motor and Kia's Robotics LAB. When used in 'overhead work' where the arm is raised, it can assist the user's upper arm muscle strength and reduce the burden on the upper extremity musculoskeletal system. The X-ble Shoulder will find use in various industries, including construction, shipbuilding, aviation and agriculture, not just automobiles. Following its domestic launch, the companies plan to gradually expand sales to overseas markets. In addition to the X-ble Shoulder, Hyundai Motor and Kia plan to develop an industrial wearable robot 'X-ble Waist' to assist the waist when lifting heavy loads, and a medical wearable robot 'X-ble MEX' for the rehabilitation of the walking impaired. "The X-ble Shoulder is a wearable robot that leverages the technical capabilities of the Robotics LAB and implements feedback from actual users," said Dong Jin Hyun , Vice President and Head of Robotics LAB at Hyundai Motor and Kia. "Going forward, we aim to expand the availability of wearable robots, creating products that work naturally with users to enhance their daily lives. By pushing technological boundaries, we will make these beneficial products accessible to more people." View original content to download multimedia: https://www.prnewswire.com/news-releases/hyundai-motor-and-kias-robotics-lab-announce-plans-to-launch-x-ble-shoulder-at-wearable-robot-tech-day-302317253.html SOURCE Hyundai Motor Company; Kia Corporation
Brazilian police indict former President Bolsonaro and aides over alleged 2022 coup attemptA pair of teams with minimal rest will face off in Nassau, Bahamas, on Sunday when No. 22 St. John takes on Georgia. St. John's (5-1), which will play its third game in four days, began the stretch in the Bahamas Championship on Thursday, dropping a heartbreaker to No. 13 Baylor. The Red Storm led by 18 in the first half before Baylor forced overtime. From there, St. John's rallied from five down with 1:47 left to send the game to a second overtime, where it saw Baylor knock down a pair of 3-pointers in the final seven seconds -- including Jeremy Roach's buzzer-beater -- to knock off the Red Storm 99-98. In the third-place game on Friday, St. John's breezed past Virginia 80-55. RJ Luis Jr. led the way with 18 points and four steals, followed by Kadary Richmond's 12 points, as the Red Storm took a one-point lead with 15:21 left in the first half and didn't trail again. "I'm really impressed with our guys, coming off a double-overtime, extremely emotional loss," St. John's head coach Rick Pitino said. "To respond that way was extremely impressive, both offensively and defensively." Pitino, in his second year with the Red Storm, was moved by something off the court on Friday, involving captain Zuby Ejiofor, who chipped in eight points, nine boards, two steals and two blocks. Ejiofor was serenaded by St. John's fans during the win, following his two missed free throws at the end of double overtime against Baylor. "When you've only been in a job for a year, you search for things you love about a place," Pitino said. "Tonight I found out what I love about St. John's. Our fans chanted Zuby's name the whole game, which doesn't happen anywhere else in America. I was really impressed with our fans and I thank them for making Zuby feel good, because he gives you all the energy." Luis leads the Red Storm with 17.3 points per game, followed by Ejiofor (10.7), Aaron Scott (10.5), Deivon Smith (10.3) and Richmond (10.2). Georgia enters Sunday's matchup looking to rebound from its first loss after falling to No. 15 Marquette 80-69 on Saturday. Georgia (5-1) battled back from a 15-point, second-half deficit, but was held to just three points over the final 4:57 in Saturday's loss. Blue Cain led the Bulldogs with a season-high 17 points, including five 3-pointers. "It's a process. It's a journey with this team," Bulldogs head coach Mike White said. "It's about continuing to make strides, continuing to protect our culture. ... At the end of the day, wins and losses are going to take care of themselves. We just have to embrace the process and enjoy it." Five-star freshman recruit Asa Newell was held to a season-low nine points but leads the team with 15.5 points per game. Silas Demary Jr. is second with 13.8. --Field Level Media
Seven-time champions Express have an opportunity to move into the top four of the Premier League if they beat Mbarara City on Thursday under floodlights at Hamz stadium, Nakivubo. The Red Eagles are on 13 points in 8 position and victory will see them move to within four points of table leaders Vipers SC who are not in action until Friday. Badru Kaddu’s men have been inconsistent in terms of wins and have registered just one win in the last five matches. In Mbarara City managed former Red Eagle Livingstone Mbabazi, they take on a resilient side that lie just two points below. The Ankole Lions ended a two-match losing streak with a deserved win over newcomers Mbale Heroes last week. Victory for the visitors whose last visit to Nakivubo ended in a stalemate with URA will come into the game very confident. Former Express player Joseph Akandwanaho will take on ex-bosses as he captains the visitors.76ers' star Paul George sidelined the next 2 games with bone bruise in left kneeThe Phase 1b trial (NCT05351502) is a clinical proof-of-concept trial that will assess the intratumoral administration of LV UNO in patients with unresectable cutaneous or subcutaneous histologically confirmed primary or metastatic lesions, who have shown disease progression or prolonged stable disease (≥ 12 weeks) after receiving a single agent anti-PD-1 containing treatment. The trial, which is expected to enroll up to 20 subjects, is designed to assess the preliminary efficacy of LV UNO by objective response rate (ORR) and duration of response (DOR) per RECIST v1.1 and secondarily immune-related response via iRECIST. Safety and tolerability of LV UNO in combination with anti-PD-1 therapy, as well as its potential to enhance the type, density, and distribution of immune cells within the tumor microenvironment will also be observed. Topline data from the Phase 1b portion of the study are anticipated in the second half of 2025. "We are excited to initiate the Phase 1b trial of LV UNO, a potentially groundbreaking solid tumor treatment approach, in combination with PD-1 inhibitors,” said Dr. Jedidiah Monson, Chief Medical Officer of Beyond Cancer. "In preclinical studies, a single dose of UNO has been shown to increase PD-L1 expression and improve overall survival in animal models compared to anti-PD-1 alone. Further, Phase 1a human data that demonstrated immune system activation were presented at ASCO's Key Opinion Leader Event held in June 2024. We look forward to the Phase 1b trial results to establish the basis of further investigation of UNO in combination with PD-1 inhibitors.” "The initiation of the Phase 1b trial represents a major step forward in our vision for personalized cancer treatment. We see UNO as a complementary therapy for future cancer treatment paradigms, particularly for patients with anti-PD-1 refractory or resistant disease, potentially offering more patients access to effective treatment,” stated Dr. Selena Chaisson, Chief Executive Officer, and Director of Beyond Cancer. About Nitric Oxide Nitric Oxide (NO) is a potent molecule, naturally synthesized in the human body, proven to play a critical role in a broad array of biological functions. In the airways, NO targets the vascular smooth muscle cells that surround the small resistance arteries in the lungs. Currently, exogenous inhaled NO is used in adult respiratory distress syndrome, post certain cardiac surgeries and persistent pulmonary hypertension of the newborn to treat hypoxemia. Additionally, NO is believed to play a key role in the innate immune system and in vitro studies suggest that NO possesses anti-microbial activity not only against common bacteria, including both gram-positive and gram-negative, but also against other diverse pathogens. About UNO Therapy for Solid Tumors Cancer is the second leading cause of death globally, with tumor metastases responsible for approximately 90% of all cancer-related deaths. Current cancer treatment modalities generally include chemotherapy, immunotherapy, radiation, and/or surgery. Ultra-high concentration Nitric Oxide (UNO) therapy is a completely new approach to preventing relapse or metastatic disease. In vitro murine data show that local tumor ablation with UNO stimulates an anti-tumor immune response in solid tumor cancer models. Beyond Cancer, Ltd. believes that UNO has the potential to prevent relapse or metastatic disease with as little as a single 5-minute treatment and with limited toxicity or off-target effects. About Beyond Cancer, Ltd. Beyond Cancer, Ltd. is a development-stage biopharmaceutical and medical device company utilizing ultra-high concentration nitric oxide (UNO) via a proprietary delivery platform to treat primary tumors and prevent metastatic disease. Nitric oxide at ultra-high concentrations has been reported to show anticancer properties and to potentially serve as a chemosensitizer and radiotherapy enhancer. A first-in-human study is underway in patients with solid tumors. Beyond Cancer is also conducting preclinical studies of UNO in multiple solid tumor models to inform additional treatment protocols. For more information, visit www.beyondcancer.com . Forward Looking Statements This press release contains "forward-looking statements” concerning the potential safety and efficacy of inhaled nitric oxide and the ultra-high concentration nitric oxide product candidate, as well as its therapeutic potential in a number of indications; and the potential impact on patients and anticipated benefits associated with inhaled nitric oxide and the ultra-high concentration nitric oxide product candidate. Forward-looking statements include statements about expectations, beliefs, or intentions regarding product offerings, business, results of operations, strategies or prospects. You can identify such forward-looking statements by the words "expects,” "plans,” "anticipates,” "believes” "expects,” "intends,” "looks forward,” "projects,” "goal,” "assumes,” "targets” and similar expressions and/or the use of future tense or conditional constructions (such as "will,” "may,” "could,” "should” and the like) and by the fact that these statements do not relate strictly to historical or current matters. Rather, forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause actual results to differ materially from any future results expressed or implied by the forward-looking statements. These forward-looking statements are only predictions and reflect views as of the date they are made with respect to future events and financial performance. Many factors could cause actual activities or results to differ materially from the activities and results anticipated in forward-looking statements, including risks related to the ability to raise additional capital; the timing and results of future pre-clinical studies and clinical trials concerning the ultra-high concentration nitric oxide product candidate; the potential that regulatory authorities, including the FDA and comparable non-U.S. regulatory authorities, may not grant or may delay approval for the ultra-high concentration nitric oxide product candidate; the approach to discover and develop novel drugs, which is unproven and may never lead to efficacious or marketable products; obtaining, maintaining and protecting intellectual property utilized by products; competition from others using similar technology and others developing products for similar uses; dependence on collaborators; and other risks, which may, in part, be identified and described in the "Risk Factors” section of Beyond Air, Inc.'s most recent Annual Report on Form 10-K and other of its filings with the Securities and Exchange Commission, all of which are available on Beyond Air, Inc.'s website. Beyond Cancer and Beyond Air undertake no obligation to update, and have no policy of updating or revising, these forward-looking statements, except as required by applicable law. CONTACTS: Corey Davis, PhD LifeSci Advisors, LLC [email protected] (212) 915-2577 Matt Johnson, Head of Corporate Development & Strategy Beyond Cancer, Ltd. [email protected]
UConn F Alex Karaban (head) won't play vs. Baylor
Crowsnest Pass vote shows 72% support Grassy Mountain coal mine
Nighdive Studios seems to have quietly announced a The Thing: Remastered release date of December 5, 2024. It’s a launch plan that will see the survival horror reimagining arriving later this week if the release date promised in a recent is accurate. The post, which was published late last week, specifically covers new Xbox game releases from December 2 through December 6, mentioning titles such as The Thaumaturge, Marvel Rivals, and early access for Indiana Jones and the Great Circle. Considering Nightdive has yet to announce a proper date and its still says launch is simply “coming soon,” The Thing: Remastered’s inclusion should raise some eyebrows. Nightdive at IGN Live in June of this year, promising to deliver a bone-chilling upgrade for the classic 2002 adaptation before 2024 came to a close. from the studio’s X/Twitter account promised that the release date is in December earlier today but did not clarify whether the December 5 date shown in the Xbox Wire post is accurate. If it is, then we shouldn’t have to wait much longer before the full experience is available for everyone to play for themselves. In addition to Xbox One and Xbox Series X | S, The Thing: Remastered is currently set to come to PC via Steam, Nintendo Switch, PlayStation 4, and PlayStation 5. Nightdive has made a name for itself as an experienced remaster studio throughout the last few years. Other titles in its catalog include remasters for the Turok trilogy, Star Wars: Dark Forces, System Shock, Shadow Man, and more. The Thing: Remastered promises a suite of additions to help bring the original experience to modern platforms. These include dynamic lighting, up to 144fps, 4K resolution, antialiasing, and other general gameplay improvements. While we wait for Nightdive to share more about its plans for The Thing: Remastered, you can read about , another one of its projects that launched earlier this year. You can also read up on , and .
Marvell Technology Inc. MRVL reported its third-quarter results after Tuesday's closing bell. Here's a look at the key figures from the quarter. The Details: Marvell Technology reported quarterly earnings of 43 cents per share, which beat the analyst consensus estimate of 41 cents. Quarterly revenue came in at $1.52 billion, which beat the consensus estimate of $1.46 billion and is an increase over sales of $1.42 billion from the same period last year. Read Next: TikTok Shop Bags More Than $100 Million In Black Friday Sales With Potential Ban Ahead “Marvell’s fiscal third quarter 2025 revenue grew 19% sequentially, well above the mid-point of our guidance, driven by strong demand from AI. For the fourth quarter, we are forecasting another 19% sequential revenue growth at the midpoint of guidance, while year-over-year, we expect revenue growth to accelerate significantly to 26%, marking the beginning of a new era of growth for Marvell,” said Matt Murphy , Marvell’s CEO. “The exceptional performance in the third quarter, and our strong forecast for the fourth quarter, are primarily driven by our custom AI silicon programs, which are now in volume production, further augmented by robust ongoing demand from cloud customers for our market-leading interconnect products. We look forward to a strong finish to this fiscal year and expect substantial momentum to continue in fiscal 2026,” Murphy added. Outlook: Marvell sees fourth-quarter earnings of 59 cents per share, plus or minus five cents, versus the 52-cent estimate. The company expects fourth-quarter revenue of $1.8 billion, plus or minus 5%, versus the $1.65 billion estimate. MRVL Price Action: According to Benzinga Pro , Marvell Technology shares are up 8.99% after-hours at $104.54 at the time of publication on Tuesday. Read More: Art Cashin’s Lessons: Cuban Crisis Trades To Timeless Wall Street Wit Photo: Shutterstock © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
SAN DIEGO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Xerox Holdings Corporation (NASDAQ: XRX) securities between January 25, 2024 and October 28, 2024. Xerox and its subsidiaries offer workplace technology that integrates hardware, services, and software for enterprises in the Americas, and internationally. For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Xerox Holdings Corporation (XRX) Misled Investors Regarding its Business Prospects According to the complaint, during the class period, defendants failed to disclose to investors that: (1) after a large workforce reduction, the Company’s salesforce was reorganized with new territory assignments and account coverage; (2) as a result, the Company’s salesforce productivity was disrupted; (3) as a result, the Company had a lower rate of sell-through of older products; (4) the difficulties in flushing out older product would delay the launch of key products; and (5) therefore, Xerox was likely to experience lower sales and revenue. Plaintiff alleges that on October 29, 2024, Xerox revealed “lower-than-expected improvements in sales force productivity” and “delays in the global launch of two new products” had led to “sales underperformance.” The Company disclosed that for third quarter 2024, quarterly revenue was down 7.5% year-over-year to $1.53 billion, net loss fell to -$1.2 billion (down $1.3 billion year-over-year), and equipment sales declined 12.2% year over year to $339 million. In a corresponding earnings call, the Company’s COO revealed the product delay was in fact a “forecasting issue” where the Company “had higher expectations that we were going to flush through the older product” which it needed to “sell through” in order to “make those transitions.” On this news, the Company’s share price fell $1.79, or 17.41%, to close at $8.49 per share on October 29, 2024. What Now: You may be eligible to participate in the class action against Xerox Holdings Corporation. Shareholders who want to serve as lead plaintiff for the class must submit their application to the court by January 21, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here . All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders. To be notified if a class action against Xerox Holdings Corporation settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today. Attorney Advertising. Past results do not guarantee a similar outcome. A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/513fb6e4-a34e-4150-8fe5-2c133087d380
Webjet: ACCC takes online travel giant to Federal Court for allegedly misleading consumers on costs
Florida knocks No. 9 Ole Miss out of College Football Playoff contention
Gilead Sciences director Jeffrey Bluestone sells $620,355 in stockNoneYou block, I’ll dodge: Does internet censorship really work?
Stock market today: Wall Street gains ground as it notches a winning week and another Dow record